30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Generate Biomedicines Inc (GENB)

Track

The most recent insider trading activity occurred on March 4, 2026. Significant buying activity was observed, with multiple transactions by NOUBAR AFEYAN and Jason Silvers, among others. The total value of these buy transactions was substantial, indicating strong insider confidence. The latest transaction was a buy by the Chief Executive Officer.
Stock chart
Ticker: GENB Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Nally Michael
Chief Executive Officer
1 purchase — total 240,000 USD
Buy 4 Mar 2026
Value US$4,128,650.56 | Price 219.10 | Shares 89,514
Buy 2 Mar 2026
Value US$3,030,742.71 | Price 315.49 | Shares 32,157
Buy 2 Mar 2026
Value US$16,000.00 | Price 16.00 | Shares 1,000
Buy 2 Mar 2026
Value US$8,000.00 | Price 16.00 | Shares 500
Buy 2 Mar 2026
Value US$8,000.00 | Price 16.00 | Shares 500
Buy 2 Mar 2026
Value US$25,000,000.00 | Price 16.00 | Shares 1,562,500
Buy 2 Mar 2026
Value US$25,000,000.00 | Price 16.00 | Shares 1,562,500
Buy 2 Mar 2026
Value US$25,000,000.00 | Price 16.00 | Shares 1,562,500
Buy 2 Mar 2026
Value US$25,000,000.00 | Price 16.00 | Shares 1,562,500
Buy 2 Mar 2026
Value US$25,000,000.00 | Price 16.00 | Shares 1,562,500
Buy 2 Mar 2026
Value US$25,000,000.00 | Price 16.00 | Shares 1,562,500
Buy 2 Mar 2026
Value US$24,000.00 | Price 16.00 | Shares 1,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-06 2026-03-04 B Purchase
Nally Michael

Chief Executive Officer

Executive Director
89,514 +28.5%
219.10
US$4,128,651 		89,514 +28.5% 219.10 US$4,128,651
2026-03-02 2026-03-02 B Purchase
Grous Beth

Chief People Officer

Officer
32,157 -17.9%
315.49
US$3,030,743 		32,157 -17.9% 315.49 US$3,030,743
2026-03-02 2026-03-02 B Purchase
Silvers Jason

President & CFO

Officer
19,365 +9.8%
80.74
US$451,790 		19,365 +9.8% 80.74 US$451,790
2026-03-02 2026-03-02 B Purchase
Silvers Jason

President & CFO

Officer
500 +inf%
16.00
US$8,000 		500 +inf% 16.00 US$8,000
2026-03-02 2026-03-02 B Purchase
Silvers Jason

President & CFO

Officer
500 +inf%
16.00
US$8,000 		500 +inf% 16.00 US$8,000
2026-03-02 2026-03-02 B Purchase
3.3
AFEYAN NOUBAR
Non-Executive Director Large shareholder
1,562,500 +inf%
16.00
US$25,000,000 		1,562,500 +inf% 16.00 US$25,000,000
2026-03-02 2026-03-02 B Purchase
3.3
AFEYAN NOUBAR
Non-Executive Director Large shareholder
1,562,500 +56.3%
16.00
US$25,000,000 		1,562,500 +56.3% 16.00 US$25,000,000
2026-03-02 2026-03-02 B Purchase
3.3
AFEYAN NOUBAR
Non-Executive Director Large shareholder
1,562,500 +11.4%
16.00
US$25,000,000 		1,562,500 +11.4% 16.00 US$25,000,000
2026-03-02 2026-03-02 B Purchase
Mendillo Jane L
Non-Executive Director
1,500 +inf%
16.00
US$24,000 		1,500 +inf% 16.00 US$24,000
2026-03-02 2026-03-02 B Purchase
3.3
AFEYAN NOUBAR
Non-Executive Director Large shareholder
1,562,500 +inf%
16.00
US$25,000,000 		1,562,500 +inf% 16.00 US$25,000,000
2026-03-02 2026-03-02 B Purchase
3.3
AFEYAN NOUBAR
Non-Executive Director Large shareholder
1,562,500 +56.3%
16.00
US$25,000,000 		1,562,500 +56.3% 16.00 US$25,000,000
2026-03-02 2026-03-02 B Purchase
3.3
AFEYAN NOUBAR
Non-Executive Director Large shareholder
1,562,500 +11.4%
16.00
US$25,000,000 		1,562,500 +11.4% 16.00 US$25,000,000
Explore more

More insider trading research around Generate Biomedicines Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America